Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-034871
Filing Date
2023-07-26
Accepted
2023-07-26 19:21:46
Documents
1
Period of Report
2023-07-24

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4095
  Complete submission text file 0000950170-23-034871.txt   5597
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Issuer) CIK: 0001822691 (see all company filings)

EIN.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC 200 BOSTON AVENUE, SUITE 3100 MEDFORD MA 02155
Business Address
Schlicher Martha (Reporting) CIK: 0001908630 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39894 | Film No.: 231114933